CC
DGX icon

Centiva Capital’s Quest Diagnostics DGX Stock Holding History

Centiva Capital’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,000
Closed -$366K – 1891
2023
Q3 		$366K Hold
3,000
– – 0.01% 1092
2023
Q2 		$422K Buy
+3,000
New +$414K 0.01% 905
2020
Q1 		– Sell
-1,200
Closed -$128K – 686
2019
Q4 		$128K Hold
1,200
– – 0.01% 717
2019
Q3 		$128K Buy
+1,200
New +$123K 0.01% 541

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Centiva Capital's DGX Position: Q3 2025 in Review

Centiva Capital sold out of Quest Diagnostics (DGX) in Q3 2025, closing a stake of 4,094 shares — an estimated $735K sold.

Centiva Capital first reported a position in DGX in Q3 2019 and held it in 13 quarters. The position peaked at $1.57M in Q4 2023. 1,006 funds tracked by Wall St. Rank hold DGX as of Q3 2025.

  • Centiva Capital reported no remaining Quest Diagnostics position as of Q3 2025 after selling out during the quarter.
  • Centiva Capital sold 4,094 Quest Diagnostics shares in Q3 2025, an estimated $735K.
  • Centiva Capital first reported a position in Quest Diagnostics in Q3 2019 and held it in 13 quarters.
  • Centiva Capital's Quest Diagnostics position peaked at $1.57M in Q4 2023.
  • 1,006 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2025.

Based on Centiva Capital's 13F filing for Q3 2025, filed 14 Nov 2025.